I agree about Carfilzomib, accelerated approval is dicey but feel pretty good about ultimate approval. If ONXX tanks because the accelerated approval is denied, I will consider buying more. I am kicking myself a bit as I considered selling about 25% of my ONXX when it hit the mid $40s, but was too slow on the trigger.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.